“…The WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate) colorimetric assay (Roche Diagnostics, Madison, WI, USA) was applied to determine the anticancer activity of the crude extract and fractions by using the human AGS gastric carcinoma cell line (ATCC, Rockville, MD, USA), human DLD-1 colon cancer cell line (ATCC, Rockville, MD, USA) and human HeLa cervix carcinoma cell line (ATCC, Rockville, MD, USA) as reported in our previous work. 11) Solutions of the sample at concentrations of 10, 100, 500, and 1000 mg/mL were added to previously incubated cells in triplicate, and the solution incubated for 48 h. A WST-1 solution was then added to each well, and the mixture incubated for 2 h at 37 C. The optical density was measured at 450 nm with an EL-800 microplate reader (BioTek instruments, Winooski, VT, USA), expressing the anticancer activity as a percentage of the cancer cell growth inhibition by the equation anticancer activity ð%Þ ¼ 100ð1 À ðA s =A c ÞÞ, where A s is the absorbance of the sample solution and A c is the absorbance of the control for which H 2 O was used instead of the sample solution.…”